OSAKA -- Induced pluripotent stem cells will soon find their way out of laboratories and into hospital rooms for treatment of an array of ailments, said the scientist who discovered this potent tool in regenerative medicine.
The cell research is "entering the second stage," said professor Shinya Yamanaka, the head of Kyoto University's Center for iPS Cell Research and Application, or CiRA. Speaking to The Nikkei Wednesday during a conference marking the 10-year anniversary of his groundbreaking discovery, the Nobel laureate said he expects iPS research to be used to treat Parkinson's disease, as well as ailments affecting blood and cartilage, in the near future.
